University of Rochester Medical Center
Dermatology residency · Rochester, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Rochester Medicine's research in dermatology, which the program shares with other departments and affiliated hospitals.
About University of Rochester Medicineinstitution-wide dermatology research
Dermatology publications from University of Rochester Medicine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
52
works per year
12th of 58 dermatology residency programs
-20.9%
2-year growth
52nd of 58 dermatology residency programs
22.1%
in top 10% of field (works before 2025)
15th of 50 dermatology residency programs
42.9%
cited above world average
18th of 50 dermatology residency programs
Works per year · * 2026 so far
Dermatology · 251
Dermatology research topics at University of Rochester Medicine
Papers in the window; each links to the list on OpenAlex.
- Dermatology and Skin Diseases 142
- Chemotherapy-related skin toxicity 31
- Dermatologic Treatments and Research 15
- Cancer and Skin Lesions 14
- Contact Dermatitis and Allergies 13
- Cutaneous lymphoproliferative disorders research 8
- Acne and Rosacea Treatments and Effects 6
- Facial Rejuvenation and Surgery Techniques 4
Most cited at University of Rochester Medicine since 2024
All dermatology papers there on OpenAlex
- Dupilumab in Adults With Moderate to Severe Atopic DermatitisLisa A. Beck et al. · JAMA Dermatology · 2024 · PubMed · cited 79
- The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trialsJonathan I. Silverberg et al. · Nature Communications · 2024 · PubMed · cited 49
- A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and ImmunologyPhil Lieberman et al. · Annals of Allergy Asthma & Immunology · 2024 · PubMed · cited 36
- Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future DirectionsMarjolein S. de Bruin-Weller et al. · Allergy · 2025 · PubMed · cited 33
- Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitisLisa A. Beck et al. · Journal of Allergy and Clinical Immunology · 2024 · PubMed · cited 31
- Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trialsDaniel G. Rayner et al. · Journal of Allergy and Clinical Immunology · 2024 · PubMed · cited 31
- Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I. Silverberg et al. · Dermatology and Therapy · 2025 · PubMed · cited 27
- Atopic Dermatitis (Eczema) Guidelines 2023: HighlightsAnna De Benedetto et al. · The Journal of Allergy and Clinical Immunology In Practice · 2024 · PubMed · cited 25
- Efficacy and safety of sequential treatment with botulinum toxin type A, fractional CO2 laser, and topical growth factor for hypertrophic scar management: a retrospective analysisJin Wang et al. · Scientific Reports · 2024 · PubMed · cited 13
- CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severityH. Mark Kenney et al. · Journal of Allergy and Clinical Immunology · 2024 · PubMed · cited 12